Document Detail

Cannabinoid CB1 receptor expression in relation to visceral adipose depots, endocannabinoid levels, microvascular damage, and the presence of the Cnr1 A3813G variant in humans.
MedLine Citation:
PMID:  19919870     Owner:  NLM     Status:  MEDLINE    
Dysregulation of the endocannabinoid system in the visceral adipose tissue (VAT) is associated with metabolic and cardiovascular complications of obesity. We studied perirenal VAT CB1 receptor expression in relation to anthropometry, VAT area and endocannabinoid levels, kidney microvascular damage (MVDa), and the presence of the CB1 gene A3813G variant, the frequency of which was also evaluated in a large population of obese-hypertensive (OH) patients with or without the metabolic syndrome (MetS). Perirenal VAT and kidney samples were obtained from 30 patients undergoing renal surgery. Total and perirenal VAT areas were determined by computed tomography. CB1 messenger RNA expression and endocannabinoid levels in perirenal VAT were determined by quantitative reverse transcriptase polymerase chain reaction and liquid chromatography-mass spectrometry, respectively. The MVDa was evaluated in healthy portions of kidney cortex. The A3813G alleles were identified by genotyping in these patients and in 280 nondiabetic OH patients (age <or=65 years). Metabolic syndrome was defined according to the Adult Treatment Panel III criteria. Perirenal VAT CB1 expression was 40% lower in patients with the A3813G polymorphism, and correlated positively with perirenal and total VAT area and with perirenal VAT levels of the endocannabinoid anandamide. A 2-fold higher CB1 expression was associated with MVDa. The OH patients with the A3813G allele had lower prevalence of MetS in both unadjusted and adjusted models. Genetics influence perirenal VAT CB1 expression and the prevalence of MetS in OH. Increased VAT is associated with increased perirenal VAT endocannabinoid tone, which in turn correlates with increased MVDa. Endocannabinoid overactivity might be involved in human visceral obesity and its renal complications.
Marica Bordicchia; Ilaria Battistoni; Lucia Mancinelli; Elena Giannini; Giada Refi; Daniele Minardi; Giovanni Muzzonigro; Roberta Mazzucchelli; Rodolfo Montironi; Fabiana Piscitelli; Stefania Petrosino; Paolo Dess?-Fulgheri; Alessandro Rappelli; Vincenzo Di Marzo; Riccardo Sarzani
Publication Detail:
Type:  Journal Article     Date:  2009-11-17
Journal Detail:
Title:  Metabolism: clinical and experimental     Volume:  59     ISSN:  1532-8600     ISO Abbreviation:  Metab. Clin. Exp.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-04-19     Completed Date:  2010-05-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375267     Medline TA:  Metabolism     Country:  United States    
Other Details:
Languages:  eng     Pagination:  734-41     Citation Subset:  IM    
Department of Internal Medicine, University of Ancona-Politecnica delle Marche, University Hospital of Ancona, Ancona, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adiponectin / blood
Endocannabinoids / metabolism*
Gene Expression Regulation
Intra-Abdominal Fat / metabolism*,  pathology
Logistic Models
Middle Aged
Obesity / genetics,  metabolism*,  pathology
Polymorphism, Single Nucleotide
RNA, Messenger / biosynthesis,  genetics
Receptor, Cannabinoid, CB1 / biosynthesis*,  genetics
Reverse Transcriptase Polymerase Chain Reaction
Tomography, X-Ray Computed
Reg. No./Substance:
0/Adiponectin; 0/Endocannabinoids; 0/RNA, Messenger; 0/Receptor, Cannabinoid, CB1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Determinants of in-hospital and long-term surgical outcomes after repair of postinfarction ventricul...
Next Document:  Twenty-eight-day bed rest with hypercortisolemia induces peripheral insulin resistance and increases...